SEC Form D · filed November 16, 2020
Elysium Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Carey G. Ng · Akron, OHDirectorKathy G. Laporte · Akron, OHDirectorJames G. Hackworth · Akron, OHDirectorBob G. Rappaport · Akron, OHDirectorThomas G. Jenkins · Akron, OHDirectorAlex G. Sturmer · Akron, OHExec · DirectorRichard A. Donato · Allison Park, PADirectorShameet M. Luhar · Columbia, MDExec · DirectorMark D. Feldman · Gibsonia, PADirectorRobert C. Erwin · Pittsburgh, PADirectorGanesh Rengaswamy · Bangalore, K7DirectorEric C. Haufler · Pittsburgh, PADirectorA. E. Barbera · Boulder, COExec · DirectorKarl Nicholls · Boulder, CODirectorMichael Kinley · Bedford, Nova Scotia, CanadaDirectorKevin Thieneman · Hilton Head Island, Nova Scotia, CanadaDirectorLara A. Riachy · Luxembourg, LuxembourgDirectorFrancois Bourgon · Luxembourg, LuxembourgDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗